TATUM Bioscience Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
6
- Latest Deal Type
-
Accelerator/Inc
- Latest Deal Amount
-
$40K
- Investors
-
14
TATUM Bioscience General Information
Description
Developer of multi-pathway immune engagers designed to stimulate antitumor immunity in cancers with limited response to checkpoint inhibitors. The company develops bioengineered nanofilaments that combine checkpoint blockade, innate immune activation, and T-cell stimulation, enabling systemic immune responses in patients with solid tumors, initially targeting colorectal cancer with liver metastases.
Contact Information
Website
www.tatumbio.comCorporate Office
- 3000 Boulevard de l'Université, Building P1-CTA
- Sherbrooke, Quebec J1K 0A5
- Canada
Corporate Office
- 3000 Boulevard de l'Université, Building P1-CTA
- Sherbrooke, Quebec J1K 0A5
- Canada
TATUM Bioscience Timeline
TATUM Bioscience Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Accelerator/Incubator | 24-Sep-2025 | $40K | Completed | Pre-Clinical Trials | ||
| 9. Accelerator/Incubator | 01-Jan-2025 | Completed | Generating Revenue | |||
| 8. Later Stage VC | 30-Nov-2024 | Completed | Generating Revenue | |||
| 7. Accelerator/Incubator | 21-May-2024 | Completed | Startup | |||
| 6. Later Stage VC | 27-Mar-2024 | Completed | Startup | |||
| 5. Early Stage VC | 17-May-2021 | Completed | Startup | |||
| 4. Accelerator/Incubator | 01-Jan-2021 | Completed | Startup | |||
| 3. Early Stage VC | 10-Mar-2020 | Completed | Startup | |||
| 2. Grant | 03-Dec-2019 | $3K | Completed | Startup | ||
| 1. Accelerator/Incubator | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
TATUM Bioscience Patents
TATUM Bioscience Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2023405587-A1 | Therapeutic bacteriophage displaying cancer cell targeting moieties along with cytokines for the treatment of cancer | Pending | 01-Dec-2022 | ||
| EP-4627066-A1 | Therapeutic bacteriophage displaying cancer cell targeting moieties along with cytokines for the treatment of cancer | Pending | 01-Dec-2022 | ||
| WO-2024113057-A1 | Therapeutic bacteriophage displaying cancer cell targeting moieties along with cytokines for the treatment of cancer | Inactive | 01-Dec-2022 | ||
| JP-2026094386-A | Live biopharmaceuticals that secrete synthetic bacteriophages in cancer treatment | Pending | 07-Oct-2020 | ||
| CA-3195020-A1 | Live biotherapeutics secreting synthetic bacteriophages in the treatment of cancer | Pending | 07-Oct-2020 | C12N15/70 |
TATUM Bioscience Signals
TATUM Bioscience Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Startup TNT | Angel Group | |||
| MassBio | Accelerator/Incubator | |||
| Capital BioVentures | Accelerator/Incubator | Minority | ||
| CQDM | Not-For-Profit Venture Capital | Minority | ||
| Investissement Quebec | PE/Buyout | Minority |
TATUM Bioscience FAQs
-
When was TATUM Bioscience founded?
TATUM Bioscience was founded in 2019.
-
Where is TATUM Bioscience headquartered?
TATUM Bioscience is headquartered in Sherbrooke, Canada.
-
What is the size of TATUM Bioscience?
TATUM Bioscience has 6 total employees.
-
What industry is TATUM Bioscience in?
TATUM Bioscience’s primary industry is Drug Discovery.
-
Is TATUM Bioscience a private or public company?
TATUM Bioscience is a Private company.
-
What is TATUM Bioscience’s current revenue?
The current revenue for TATUM Bioscience is .
-
How much funding has TATUM Bioscience raised over time?
TATUM Bioscience has raised $2.66M.
-
Who are TATUM Bioscience’s investors?
Startup TNT, MassBio, Capital BioVentures, CQDM, and Investissement Quebec are 5 of 14 investors who have invested in TATUM Bioscience.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process